Sun Hongkui, Chen Miaolian, Huang Xiaoxing
Critical Care Department, Zhongshan City People's Hospital, Zhongshan, Guangdong Province, China.
Medical Imaging Center, Zhongshan City People's Hospital, Zhongshan, Guangdong Province, China.
Eur J Clin Microbiol Infect Dis. 2025 Jun 26. doi: 10.1007/s10096-025-05197-3.
This study investigates the clinical, microbiological, and prognostic variations between hypermucoviscous Klebsiella pneumoniae (hmKp) and non-hypermucoviscous Kp (n-hmKp) infections.
A total of 381 cases of community-acquired Klebsiella pneumoniae (cKp) infections at Zhongshan People's Hospital between January 2019 and November 2024 were analyzed. Infection characteristics, mortality risk factors, and antimicrobial susceptibility profiles were compared between hmKp and n-hmKp groups.
No significant differences were observed between patients infected with n-hmKp and hmKp in terms of median age, gender, underlying conditions, hospital stay, ICU stay, and hospital mortality rates (all P > 0.05). However, the SOFA score was higher, and shock occurred more frequently in hmKp infections (all P < 0.05). In addition, hmKp exhibits a higher propensity for inducing invasive infections (P = 0.000). Multivariable logistic regression identified higher median age (OR: 1.08, P = 0.005), and tumors (OR: 5.73, P = 0.035) as risk factors for mortality in n-hmKp infections. Conversely, higher SOFA scores (OR: 2.08, P = 0.000), shock (OR: 48.55, P = 0.001), and elevated levels of procalcitonin (OR: 0.96, P = 0.019), lactic acid (OR: 1.78, P = 0.015), and troponin T (OR: 1.01, P = 0.029) were associated with mortality in hmKp infections. Both hmKp and n-hmKp strains exhibited varying degrees of antibiotic resistance, with n-hmKp strains demonstrating higher resistance to common antibiotics, especially for ceftriaxone, imipenem, and piperacillin-tazobactam compared to hmKp strains (all P < 0.05).
N-hmKp and hmKp exhibit significant differences in both clinical and microbiological characteristics. Heightened awareness of them is essential for effective management.
本研究调查高黏液性肺炎克雷伯菌(hmKp)感染与非高黏液性肺炎克雷伯菌(n-hmKp)感染之间的临床、微生物学及预后差异。
分析2019年1月至2024年11月期间中山市人民医院381例社区获得性肺炎克雷伯菌(cKp)感染病例。比较hmKp组和n-hmKp组的感染特征、死亡风险因素及抗菌药物敏感性谱。
n-hmKp感染患者与hmKp感染患者在中位年龄、性别、基础疾病、住院时间、入住重症监护病房时间及医院死亡率方面均无显著差异(所有P>0.05)。然而,hmKp感染患者的序贯器官衰竭评估(SOFA)评分更高,休克发生率更高(所有P<0.05)。此外,hmKp引发侵袭性感染的倾向更高(P=0.000)。多因素logistic回归分析确定,较高的中位年龄(比值比[OR]:1.08,P=0.005)和肿瘤(OR:5.73,P=0.035)是非高黏液性肺炎克雷伯菌感染患者死亡的危险因素。相反,较高的SOFA评分(OR:2.08,P=0.000)、休克(OR:48.55,P=0.001)以及降钙素原(OR:0.96,P=0.019)、乳酸(OR:1.78,P=0.015)和肌钙蛋白T(OR:1.01,P=0.029)水平升高与高黏液性肺炎克雷伯菌感染患者的死亡相关。hmKp和n-hmKp菌株均表现出不同程度的抗生素耐药性,与hmKp菌株相比,n-hmKp菌株对常用抗生素的耐药性更高,尤其是对头孢曲松、亚胺培南和哌拉西林-他唑巴坦(所有P<0.05)。
n-hmKp和hmKp在临床和微生物学特征方面均存在显著差异。提高对它们的认识对于有效管理至关重要。